Review: Inducer of cytokines in vivo: Overview of field and romurtide experience
- 30 April 1992
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (3), 487-496
- https://doi.org/10.1016/0192-0561(92)90180-s
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Muroctasin [MDP-Lys(18)] augments the production of granulocyte colony-stimulating factor (G-CSF) from human peripheral blood mononuclear cells in vitroInternational Journal of Immunopharmacology, 1990
- Effect of Nα-acetylmuramyl-l-alanyl-d-isoglutaminyl-Nϵ-stearoyl-l-lysine on resistance to herpes simplex virus type-1 infection in cyclophosphamide-treated miceVaccine, 1989
- Prophylactic activity against Sendai virus infection and macrophage activation with lipophilic derivatives of N-acetylglucosaminylmuramyl tri- or tetrapeptidesVaccine, 1989
- Immunological activities of multiprenylacetyl derivatives of muramyldipeptidesVaccine, 1988
- Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor.Journal of Clinical Investigation, 1988
- Suppression of Sendai virus growth by treatment with N--N--- in miceVaccine, 1987
- Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in miceVaccine, 1985
- Effect ofVaccine, 1984
- Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factorCellular Immunology, 1980
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974